NO981781L - Ekstrakter av haibrusk - Google Patents

Ekstrakter av haibrusk

Info

Publication number
NO981781L
NO981781L NO981781A NO981781A NO981781L NO 981781 L NO981781 L NO 981781L NO 981781 A NO981781 A NO 981781A NO 981781 A NO981781 A NO 981781A NO 981781 L NO981781 L NO 981781L
Authority
NO
Norway
Prior art keywords
extracts
extract
liquid extract
cartilage
cartilage extracts
Prior art date
Application number
NO981781A
Other languages
English (en)
Norwegian (no)
Other versions
NO981781D0 (no
Inventor
Eric Dupont
Paul Brazeau
Christina Juneau
Daniel H Maes
Kenneth Marenus
Original Assignee
Aeterna Lab Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aeterna Lab Inc filed Critical Aeterna Lab Inc
Publication of NO981781D0 publication Critical patent/NO981781D0/no
Publication of NO981781L publication Critical patent/NO981781L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/98—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin
    • A61K8/987—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin of species other than mammals or birds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56—Materials from animals other than mammals
    • A61K35/60—Fish, e.g. seahorses; Fish eggs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/14—Drugs for dermatological disorders for baldness or alopecia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/74—Biological properties of particular ingredients
    • A61K2800/75—Anti-irritant

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Vascular Medicine (AREA)
  • Rheumatology (AREA)
  • Birds (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Zoology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Transplantation (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Urology & Nephrology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Cosmetics (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Meat, Egg Or Seafood Products (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Separation Using Semi-Permeable Membranes (AREA)
  • Treatment Of Liquids With Adsorbents In General (AREA)
  • Medicinal Preparation (AREA)
NO981781A 1995-10-30 1998-04-21 Ekstrakter av haibrusk NO981781L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/550,003 US6025334A (en) 1994-04-28 1995-10-30 Extracts of shark cartilage having anti-collagenolytic, anti-inflammatory, anti-angiogenic and anti-tumoral activities; process of making, methods of using and compositions thereof
PCT/CA1996/000549 WO1997016197A1 (en) 1995-10-30 1996-08-07 Extracts of shark cartilage

Publications (2)

Publication Number Publication Date
NO981781D0 NO981781D0 (no) 1998-04-21
NO981781L true NO981781L (no) 1998-06-19

Family

ID=24195326

Family Applications (1)

Application Number Title Priority Date Filing Date
NO981781A NO981781L (no) 1995-10-30 1998-04-21 Ekstrakter av haibrusk

Country Status (28)

Country Link
US (1) US6025334A (ro)
EP (1) EP0859622B1 (ro)
JP (2) JPH11513990A (ro)
KR (1) KR100296016B1 (ro)
CN (1) CN1187060C (ro)
AT (1) ATE230604T1 (ro)
BG (1) BG63907B1 (ro)
BR (1) BR9611507A (ro)
CA (1) CA2236021C (ro)
CO (1) CO4750839A1 (ro)
CZ (1) CZ129398A3 (ro)
DE (1) DE69625698T2 (ro)
DK (1) DK0859622T3 (ro)
ES (1) ES2190475T3 (ro)
HK (1) HK1015683A1 (ro)
HU (1) HU225490B1 (ro)
IL (1) IL119030A (ro)
IN (1) IN188198B (ro)
IS (1) IS2017B (ro)
MX (1) MX9803419A (ro)
NO (1) NO981781L (ro)
NZ (1) NZ313957A (ro)
PL (1) PL187989B1 (ro)
RO (1) RO118567B1 (ro)
RU (1) RU2181292C2 (ro)
TW (1) TW503108B (ro)
WO (1) WO1997016197A1 (ro)
ZA (1) ZA966726B (ro)

Families Citing this family (54)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6380366B1 (en) * 1994-04-28 2002-04-30 Les Laboratoires Aeterna Inc. Shark cartilage extract:process of making, methods of using and compositions thereof
GB9621630D0 (en) * 1996-10-17 1996-12-11 Kappa Pharmaceuticals Ltd Treatment of skin disorders
EP0842670A1 (en) * 1996-11-13 1998-05-20 Katsunari Nishihara Biomedical materials
CA2288269A1 (en) 1997-02-20 1998-08-27 Industrial Research Limited Angiogenesis inhibitors and activators from shark cartilage
WO1998040088A1 (en) 1997-03-11 1998-09-17 Les Laboratoires Aeterna Inc. Compositions for treating tumors containing shark cartilage extracts and anti-neoplastic agents
CN1288165C (zh) * 1997-07-11 2006-12-06 Cv技术公司 用于治疗与phf过多或细胞内钙过多相关疾病的来自鲨软骨的制剂
JPH11171782A (ja) * 1997-12-03 1999-06-29 Kaoru Yamane 液体鮫軟骨の製造方法
FR2778558B1 (fr) * 1998-05-12 2001-02-16 Oreal Utilisation d'inhibiteur de metalloproteinases pour induire et/ou stimuler la croissance des cheveux ou des poils et/ou freiner leur chute
US6168807B1 (en) * 1998-07-23 2001-01-02 Les Laboratoires Aeterna Inc. Low molecular weight components of shark cartilage, processes for their preparation and therapeutic uses thereof
US20020009501A1 (en) * 1998-07-23 2002-01-24 Eric Dupont Preparation of cartilage extracts using organic solvents
WO2000010552A2 (en) * 1998-08-24 2000-03-02 Global Vascular Concepts, Inc. Use of anti-angiogenic agents for inhibiting vessel wall injury
KR100355952B1 (ko) * 2000-03-15 2002-10-11 주식회사 코리아나화장품 상어 연골추출물과 비타민 케이 유도체를 함유하는 화장료조성물
AU2001242502A1 (en) * 2000-03-31 2001-10-15 Henkel Kommanditgesellschaft Auf Aktien Use of protease inhibitors in cosmetics and pharmacy
CN1245991C (zh) * 2000-12-20 2006-03-22 工业研究有限公司 鲨鱼肉提取物
TWI233361B (en) * 2001-04-13 2005-06-01 Gen Hospital Corp Methods of preventing UVB-induced skin damage
WO2003018620A2 (en) * 2001-08-27 2003-03-06 Les Laboratoires Aeterna Inc. Serine protease inhibitor and processes for the preparation thereof
US7504115B2 (en) 2002-02-15 2009-03-17 Ocean Nutrition Canada Limited Shark cartilage extracts and use thereof for immunomodulation
US20080063677A1 (en) * 2004-03-10 2008-03-13 New Life Resources, Llc Therapeutic, nutraceutical and cosmetic applications for eggshell membrane and processed eggshell membrane preparations
JPWO2004083257A1 (ja) * 2003-03-20 2006-06-22 ホソカワミクロン株式会社 軟骨魚類から単離されたプロテオグリカンおよびその製造方法
US20050222687A1 (en) * 2004-04-02 2005-10-06 Gordana Vunjak-Novakovic Cartilage implant assembly and method for implantation
US7067123B2 (en) * 2003-04-29 2006-06-27 Musculoskeletal Transplant Foundation Glue for cartilage repair
US20090291112A1 (en) * 2003-05-16 2009-11-26 Truncale Katherine G Allograft osteochondral plug combined with cartilage particle mixture
US7901457B2 (en) * 2003-05-16 2011-03-08 Musculoskeletal Transplant Foundation Cartilage allograft plug
ES2223291B1 (es) * 2003-08-06 2006-03-16 Bioiberica, S.A. Nuevo uso terapeutico de condroitin sulfato.
EP2338441B1 (en) 2003-12-11 2013-01-23 Isto Technologies Inc. Particulate cartilage system
JP4390809B2 (ja) * 2004-01-07 2009-12-24 イーエルシー マネージメント エルエルシー 発毛遅延のための化粧品組成物及び方法
US8580315B2 (en) * 2004-03-10 2013-11-12 Esm Technologies, Llc Anti-inflammatory activity of eggshell membrane and processed eggshell membrane preparations
US20050288796A1 (en) * 2004-06-23 2005-12-29 Hani Awad Native soft tissue matrix for therapeutic applications
US7837740B2 (en) * 2007-01-24 2010-11-23 Musculoskeletal Transplant Foundation Two piece cancellous construct for cartilage repair
US20080220044A1 (en) * 2007-03-06 2008-09-11 Semler Eric J Cancellous construct with support ring for repair of osteochondral defects
WO2006059236A2 (en) * 2004-11-16 2006-06-08 Aeterna Zentaris Inc. Method of using cartilage extract for increasing blood parameters
US7815926B2 (en) 2005-07-11 2010-10-19 Musculoskeletal Transplant Foundation Implant for articular cartilage repair
JP4875865B2 (ja) * 2005-08-17 2012-02-15 株式会社日本バリアフリー 変形性関節症の予防及び治療用ＮＴｘ値低減剤
WO2007025290A2 (en) 2005-08-26 2007-03-01 Isto Technologies, Inc. Implants and methods for repair, replacement and treatment of joint disease
CA2623106C (en) 2005-09-19 2013-12-24 Histogenics Corporation Cell-support matrix having narrowly defined uniformly vertically and non-randomly organized porosity and pore density and a method for preparation thereof
JP4834671B2 (ja) 2005-09-29 2011-12-14 株式会社マルハニチロ水産 成人病の予防及び治療に有効な組成物
US20080154233A1 (en) * 2006-12-20 2008-06-26 Zimmer Orthobiologics, Inc. Apparatus for delivering a biocompatible material to a surgical site and method of using same
US8163549B2 (en) 2006-12-20 2012-04-24 Zimmer Orthobiologics, Inc. Method of obtaining viable small tissue particles and use for tissue repair
US8435551B2 (en) * 2007-03-06 2013-05-07 Musculoskeletal Transplant Foundation Cancellous construct with support ring for repair of osteochondral defects
AU2008240191B2 (en) 2007-04-12 2013-09-19 Zimmer, Inc. Compositions and methods for tissue repair
CA2708147A1 (en) * 2007-12-05 2009-06-18 Musculoskeletal Transplant Foundation Cancellous bone implant for cartilage repair
EP2265220A1 (en) 2008-03-05 2010-12-29 Musculoskeletal Transplant Foundation Cancellous constructs, cartilage particles and combinations of cancellous constructs and cartilage particles
EP2262469A4 (en) * 2008-04-15 2013-12-04 Immanence Integrale Dermo Correction Inc SKIN CARE COMPOSITIONS AND METHODS OF USE
CN103429608B (zh) * 2011-01-19 2016-08-03 国立大学法人弘前大学 蛋白多糖的大量制备方法
ES2403804B1 (es) * 2011-09-21 2014-07-15 Bioib�Rica, S.A. Producto de cartílago.
US9347081B2 (en) 2011-04-19 2016-05-24 Bioiberica, S.A. Cartilage product
US20140178343A1 (en) 2012-12-21 2014-06-26 Jian Q. Yao Supports and methods for promoting integration of cartilage tissue explants
RU2526825C1 (ru) * 2013-06-18 2014-08-27 Вера Геннадьевна Лихванцева Фармацевтическая антиангиогенная композиция для лечения заболеваний глаз
US10077420B2 (en) 2014-12-02 2018-09-18 Histogenics Corporation Cell and tissue culture container
CN104877009B (zh) * 2015-05-11 2020-08-11 浙江海洋学院 一种赤魟软骨多肽类血管生成抑制因子
KR101901568B1 (ko) 2016-07-04 2018-09-28 주식회사 강스템바이오텍 연골 무세포 파쇄물 및 줄기세포를 포함하는 연골분화 촉진용 복합체 및 그의 용도
KR102154976B1 (ko) * 2018-08-30 2020-09-11 전남대학교산학협력단 구내염 치료용 하이드로겔
KR102369902B1 (ko) * 2021-04-23 2022-03-02 이수한 전 처리된 캐비아가 함유된 철갑상어 진액 및 그 제조 방법
KR20220166032A (ko) 2021-06-09 2022-12-16 아스코코리아 주식회사 조립식 캠핑 테이블

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3478146A (en) * 1965-02-26 1969-11-11 Leslie L Balassa Wound-healing cartilage powder extracting process
US4042457A (en) * 1975-11-10 1977-08-16 Rush-Presbyterian-St. Luke's Medical Center Preparation of tissue invasion inhibitor and method of treatment utilizing the inhibitor
US4822607A (en) * 1976-10-29 1989-04-18 Lescarden Ltd. Anti-tumor agent and method
US4243582A (en) * 1979-04-26 1981-01-06 Monsanto Company Novel glycoproteins from bovine cartilage
US4350682A (en) * 1979-05-11 1982-09-21 Lescarden Ltd. Cartilage extraction processes and products
US4356261A (en) * 1980-04-22 1982-10-26 Rush-Presbyterian-St. Luke's Medical Center Anti-invasion factor containing cultures
US4473551A (en) * 1982-08-23 1984-09-25 Faxon Pharmaceuticals, Inc. Anti-inflammatory composition
US4656137A (en) * 1985-09-12 1987-04-07 Lescarden Inc Method of processing animal cartilage
US4749522A (en) * 1985-10-31 1988-06-07 Angio-Medical Corporation Supercritical fluid extraction of animal derived materials
US4746729A (en) * 1986-07-30 1988-05-24 Kuettner Klaus E Cartilage-derived leukocyte elastase-inhibitor
US5075112A (en) * 1990-02-12 1991-12-24 Cartilage Technologies Inc. Method of and dosage unit for inhibiting angiogenesis or vascularization in an animal using shark cartilage
AU5596494A (en) * 1992-11-30 1994-06-22 I. William Lane Processing shark cartilage
NZ533467A (en) * 1993-07-19 2006-02-24 Angiotech Pharm Inc Anti-angiogenic compositions and methods of use
US5618925A (en) * 1994-04-28 1997-04-08 Les Laboratories Aeterna Inc. Extracts of shark cartilage having an anti-angiogenic activity and an effect on tumor regression; process of making thereof
JPH0870822A (ja) * 1994-09-01 1996-03-19 Makoma Kk カプセル入り食品及びその製造法
CZ292627B6 (cs) * 1995-02-03 2003-11-12 Les Laboratoires Aeterna Inc. Léčivo pro léčení nemocí nebo poruch majících složku kolagenolytickou nebo zánětlivou

Also Published As

Publication number Publication date
IN188198B (ro) 2002-08-31
HU225490B1 (en) 2006-12-28
BG63907B1 (bg) 2003-06-30
CN1206348A (zh) 1999-01-27
IL119030A0 (en) 1996-11-14
CA2236021A1 (en) 1997-05-09
RO118567B1 (ro) 2003-07-30
JP2003246740A (ja) 2003-09-02
PL187989B1 (pl) 2004-11-30
DK0859622T3 (da) 2003-05-05
EP0859622A1 (en) 1998-08-26
BG102419A (en) 1999-01-29
IS2017B (is) 2005-06-15
KR19990067245A (ko) 1999-08-16
BR9611507A (pt) 1999-12-28
CA2236021C (en) 2002-07-30
KR100296016B1 (ko) 2001-10-26
ZA966726B (en) 1997-02-18
CO4750839A1 (es) 1999-03-31
DE69625698D1 (de) 2003-02-13
TW503108B (en) 2002-09-21
ES2190475T3 (es) 2003-08-01
IS4728A (is) 1998-04-29
HUP9802604A2 (hu) 1999-10-28
EP0859622B1 (en) 2003-01-08
ATE230604T1 (de) 2003-01-15
CZ129398A3 (cs) 1998-12-16
DE69625698T2 (de) 2003-10-16
PL326888A1 (en) 1998-10-26
NZ313957A (en) 2000-05-26
NO981781D0 (no) 1998-04-21
IL119030A (en) 2000-08-13
CN1187060C (zh) 2005-02-02
RU2181292C2 (ru) 2002-04-20
MX9803419A (es) 1998-10-31
HUP9802604A3 (en) 2001-06-28
US6025334A (en) 2000-02-15
JPH11513990A (ja) 1999-11-30
WO1997016197A1 (en) 1997-05-09
HK1015683A1 (en) 1999-10-22

Similar Documents

Publication Publication Date Title
NO981781L (no) Ekstrakter av haibrusk
NO973564L (no) Ekstrakter av haibrusk, fremgangsmåte til fremstilling og anvendelse derav
NO964547D0 (no) Ekstrakter av haibrusk som har antiangiogenaktivitet og en virkning på tumorregresjon og fremgangsmåte til fremstilling derav
KR100564824B1 (ko) 적어도 하나의 야생 망고 나무 추출물이 화장품 및 약품으로 사용되는 용도
CN105769727B (zh) 一种含海参水煮液提取物的美白护肤品及其制备方法
KR20200041667A (ko) 피부 개선용 화장료 조성물 및 이의 제조 방법
KR102299952B1 (ko) 산초 과피 추출물이 함유된 아토피 크림 제조방법
CN108379189A (zh) 一种护肤霜及其制备方法
JPH06336423A (ja) 皮膚外用剤
CN108653084B (zh) 一种含生长因子的男士用护肤组合物及其应用
CN109745257A (zh) 一种具有祛痘功效的化妆品制剂及其制备方法
KR100633517B1 (ko) 세크로피아속 식물 추출물의 용도
JPH07330624A (ja) 抗炎症、抗かゆみ剤
JP2020172468A (ja) 分子シャペロン誘導剤
Inderbitzin Studies on the permeability increasing factor (PIF) in skin extracts
CN109464311A (zh) 一种美白抗敏抗衰老复方精油及其制备方法
JPS63174911A (ja) 皮膚外用剤
CN118546922A (zh) 一种化妆品dna钠原料及其美白防晒应用和制备方法
Kutushev et al. Treatment of transtrochanteric fractures of the femur
KR20020027888A (ko) 모세혈관 확장증에 유용한 화장품
JPH07112919A (ja) 養毛剤及びこれを含有する頭髪用化粧料

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application